The Effects of Metformin on Cisplatin‐Induced Ototoxicity in Diabetic Patients
Contrary to expectations from preclinical data, metformin did not reduce the incidence of hearing loss in patients receiving cisplatin and may, in fact, be associated with an increased risk.
Authors
- Jack Phan (ORCID: https://orcid.org/0000-0001-5977-6004)
- Paul W. Gidley (ORCID: https://orcid.org/0000-0003-3706-8781)
- Taylor Myers
- Katherine A. Hutcheson (ORCID: https://orcid.org/0000-0003-3710-5706)
- Cindy You (ORCID: https://orcid.org/0000-0002-4189-8406)
- Katharine Fernandez (ORCID: https://orcid.org/0000-0003-0522-388X)
- Jonathan S. Choi (ORCID: https://orcid.org/0000-0003-2008-518X)
- Rajarshi Pratihar (ORCID: https://orcid.org/0000-0003-3042-8131)
- Shirin Jivani
- Marc‐Elie Nader (ORCID: https://orcid.org/0000-0001-9295-0174)
- Mike Hernández (ORCID: https://orcid.org/0000-0002-5074-5460)
Institutions
- National Institutes of Health (US)
- The University of Texas MD Anderson Cancer Center (US)
- Weatherford (United States) (US)
- National Institute on Deafness and Other Communication Disorders (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Otolaryngology
- Published
- 2024-10-26
- DOI
- https://doi.org/10.1002/ohn.1032
- Citations
- 1
- Primary Topic
- Synthesis of Organic Compounds
- Type
- article
- Field-Weighted Citation Impact
- 0.45